Skip to main content
Log in

Preoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgery

  • Letter to the Editor
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 15 September 2021

The Original Article was published on 08 July 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Avau B, Van Remoortel H, Laermans J, Bekkering G, Fergusson D, Georgsen J, et al. Lack of cost-effectiveness of preoperative erythropoiesis-stimulating agents and/or iron therapy in anaemic, elective surgery patients: a systematic review and updated analysis. Pharmacoeconomics. 2021. https://doi.org/10.1007/s40273-021-01044-3.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Coyle D, Lee KM, Fergusson DA, Laupacis A. Economic analysis of erythropoietin use in orthopaedic surgery. Transfus Med. 1999;9(1):21–30.

    Article  CAS  Google Scholar 

  3. Coyle D, Lee KM, Fergusson DA, Laupacis A. Cost effectiveness of epoetin-alpha to augment preoperative autologous blood donation in elective cardiac surgery. Pharmacoeconomics. 2000;18(2):161–71.

    Article  CAS  Google Scholar 

  4. Craig J, Brown H, Eastgate J, Macpherson K, Wilson S. In: The use of epoetin alfa before orthopaedic surgery in patients with mild anaemia. Understanding our advice: the use of epoetin alfa before orthopaedic surgery in patients with mild anaemia. 2006 Quality Improvement Scotland.

  5. Basora M, Pereira A, Coca M, Tio M, Lozano L. Cost-effectiveness analysis of ferric carboxymaltose in pre-operative haemoglobin optimisation in patients undergoing primary knee arthroplasty. Blood Transfus. 2018;16(5):438–42.

    PubMed  PubMed Central  Google Scholar 

  6. Trentino KM, Mace HS, Symons K, Sanfilippo FM, Leahy MF, Farmer SL, et al. Screening and treating pre-operative anaemia and suboptimal iron stores in elective colorectal surgery: a cost effectiveness analysis. Anaesthesia. 2020. https://doi.org/10.1111/anae.15240.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kevin M. Trentino.

Ethics declarations

Funding

This manuscript received no funding.

Conflicts of interest

Mr. Trentino and Dr. Mace have nothing to disclose. Dr. Hofmann reports personal fees and non-financial support from Celgene, Belgium, personal fees and non-financial support from G1 Therapeutics, non-financial support from South African National Blood Service, South Africa, personal fees and non-financial support from Takeda, South Africa, personal fees and non-financial support from TEM Innovations, Germany, personal fees and non-financial support from Vifor Pharma International AG, Switzerland, and personal fees from Vygon SA, France, outside the submitted work.

Availability of data and material

Not applicable.

Code availability

Not applicable.

Authors' contributions

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trentino, K.M., Mace, H. & Hofmann, A. Preoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgery. PharmacoEconomics 40, 133–135 (2022). https://doi.org/10.1007/s40273-021-01083-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-021-01083-w

Navigation